A Phase 1/2, open-label, multi-arm study, of AGEN1884 in combination with AGEN2034 in subjects with cervical cancer

Type of Cancer
Gynecologic

Site
Bethesda

Protocol Number
Cervical cancer

To Learn More Call
(201)-510-0950